Literature DB >> 10538480

Changing disease definitions: implications for disease prevalence. Analysis of the Third National Health and Nutrition Examination Survey, 1988-1994.

L M Schwartz1, S Woloshin.   

Abstract

CONTEXT: In the hope of extending treatment benefits to patients with early disease, various professional societies have recommended changing several common disease definitions by lowering the threshold value for diagnosis. COUNT: Number of Americans labeled "diseased" under new definitions for diabetes, hypertension, hypercholesterolemia, and being overweight. CALCULATION: [symbol: see text] DATA SOURCE: Adult participants (age > 17 years) in the Third National Health and Nutrition Examination Survey (1988-1994).
RESULTS: Adopting the new definitions would dramatically inflate disease prevalence. Changing the threshold for diabetes from a fasting glucose level of > or = 140 mg/dL to > or = 126 mg/dL would result in 1.7 million new cases. Redefining hypertension as systolic blood pressure > or = 140 mm Hg instead of > or = 160 mm Hg or diastolic blood pressure > or = 90 mm Hg instead of > or = 100 mm Hg would create 13 million new hypertensive patients. For hypercholesterolemia (a cholesterol level of > or = 200 mg/dL instead of > or = 240 mg/dL) and being overweight (body mass index > or = 25 kg/m2 instead of > or = 27 kg/m2), the number of new cases would be 42 million and 29 million, respectively. The new definitions ultimately label 75% of the adult U.S. population as diseased.
CONCLUSIONS: If these modest changes in disease definition were adopted, great numbers of people would be considered diseased. The extent to which new "patients" would ultimately benefit from early detection and treatment of these conditions is unknown. Whether they would experience important physical or psychological harm is an open question.

Entities:  

Mesh:

Year:  1999        PMID: 10538480

Source DB:  PubMed          Journal:  Eff Clin Pract        ISSN: 1099-8128


  16 in total

Review 1.  The increasing necessity for market-based pharmaceutical prices.

Authors:  J E Calfee
Journal:  Pharmacoeconomics       Date:  2000       Impact factor: 4.981

Review 2.  New paradigms for quality in primary care.

Authors:  B Starfield
Journal:  Br J Gen Pract       Date:  2001-04       Impact factor: 5.386

3.  The making of a disease: female sexual dysfunction. Without industry funding little new research will be possible.

Authors:  Rosemary Basson; Sandra Leiblum
Journal:  BMJ       Date:  2003-03-22

4.  Impact of diastolic and systolic blood pressure on mortality: implications for the definition of "normal".

Authors:  Brent C Taylor; Timothy J Wilt; H Gilbert Welch
Journal:  J Gen Intern Med       Date:  2011-03-15       Impact factor: 5.128

Review 5.  Does true Gleason pattern 3 merit its cancer descriptor?

Authors:  Saiful Miah; Hashim U Ahmed; Alex Freeman; Mark Emberton
Journal:  Nat Rev Urol       Date:  2016-08-17       Impact factor: 14.432

6.  Impact of obesity on health-related quality of life in patients with chronic illness.

Authors:  D A Katz; C A McHorney; R L Atkinson
Journal:  J Gen Intern Med       Date:  2000-11       Impact factor: 5.128

7.  Diagnosis, narrative identity, and asymptomatic disease.

Authors:  Mary Jean Walker; Wendy A Rogers
Journal:  Theor Med Bioeth       Date:  2017-08

Review 8.  Hypertension and current issues in compliance and patient outcomes.

Authors:  T M Zyczynski; K S Coyne
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

9.  Effect of Varying Definitions of Hypopnea on the Diagnosis and Clinical Outcomes of Sleep-Disordered Breathing: A Systematic Review and Meta-Analysis.

Authors:  Meghna P Mansukhani; Bhanu Prakash Kolla; Zhen Wang; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

10.  Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study.

Authors:  Susan Cheng; Brian Claggett; Andrew W Correia; Amil M Shah; Deepak K Gupta; Hicham Skali; Hanyu Ni; Wayne D Rosamond; Gerardo Heiss; Aaron R Folsom; Josef Coresh; Scott D Solomon
Journal:  Circulation       Date:  2014-08-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.